Skip to main content
SpringerLink
Log in

Continuing interventions in a quality improvement bundle to reduce bronchopulmonary dysplasia

  • Commentary
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

Not applicable.

References

  1. Kalikkot Thekkeveedu R, Guaman MC, Shivanna B. Bronchopulmonary dysplasia: a review of pathogenesis and pathophysiology. Respir Med. 2017;132:170–7.

    PubMed  Google Scholar 

  2. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357–68.

    PubMed  Google Scholar 

  3. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;163:1723–9.

    CAS  PubMed  Google Scholar 

  4. Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, et al. Bronchopulmonary dysplasia: executive summary of a workshop. J Pediatr. 2018;197:300–8.

    PubMed  PubMed Central  Google Scholar 

  5. Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 2019;200:751–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Kirpalani H, Ratcliffe SJ, Keszler M, Davis PG, Foglia EE, Te Pas A, et al. Effect of sustained inflations vs intermittent positive pressure ventilation on bronchopulmonary dysplasia or death among extremely preterm infants: the SAIL randomized clinical trial. JAMA. 2019;321:1165–75.

    PubMed  PubMed Central  Google Scholar 

  7. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A, et al. European consensus guidelines on the management of respiratory distress syndrome - 2019 update. Neonatology. 2019;115:432–50.

    PubMed  Google Scholar 

  8. Aldana-Aguirre JC, Pinto M, Featherstone RM, Kumar M. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2017;102:F17–23.

    PubMed  Google Scholar 

  9. Dargaville PA, Ali SKM, Jackson HD, Williams C, De Paoli AG. Impact of minimally invasive surfactant therapy in preterm infants at 29–32 weeks gestation. Neonatology. 2018;113:7–14.

    CAS  PubMed  Google Scholar 

  10. Behnke J, Lemyre B, Czernik C, Zimmer KP, Ehrhardt H, Waitz M. Non-invasive ventilation in neonatology. Dtsch Arztebl Int. 2019;116:177–83.

    PubMed  PubMed Central  Google Scholar 

  11. Schmolzer GM, Kumar M, Pichler G, Aziz K, O’Reilly M, Cheung PY. Non-invasive versus invasive respiratory support in preterm infants at birth: systematic review and meta-analysis. BMJ. 2013;347:f5980.

    PubMed  PubMed Central  Google Scholar 

  12. Subramaniam P, Ho JJ, Davis PG. Prophylactic or very early initiation of continuous positive airway pressure (CPAP) for preterm infants. Cochrane Database Syst Rev. 2021;10:CD001243.

    PubMed  Google Scholar 

  13. Lemyre B, Laughon M, Bose C, Davis PG. Early nasal intermittent positive pressure ventilation (NIPPV) versus early nasal continuous positive airway pressure (NCPAP) for preterm infants. Cochrane Database Syst Rev. 2016;12:CD005384.

    PubMed  Google Scholar 

  14. Chen L, Wang L, Li J, Wang N, Shi Y. Noninvasive ventilation for preterm twin neonates with respiratory distress syndrome: a randomized controlled trial. Sci Rep. 2015;5:14483.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Ramaswamy VV, More K, Roehr CC, Bandiya P, Nangia S. Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome: systematic review and network meta-analysis. Pediatr Pulmonol. 2020;55:2940–63.

    PubMed  Google Scholar 

  16. Lemyre B, Davis PG, De Paoli AG, Kirpalani H. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation. Cochrane Database Syst Rev. 2017;2:CD003212.

    PubMed  Google Scholar 

  17. Masry A, Nimeri N, Koobar O, Hammoudeh S, Chandra P, Elmalik EE, et al. Reintubation rates after extubation to different non-invasive ventilation modes in preterm infants. BMC Pediatr. 2021;21:281.

    PubMed  PubMed Central  Google Scholar 

  18. Fleeman N, Dundar Y, Shah PS, Shaw BN. Heated humidified high-flow nasal cannula for preterm infants: an updated systematic review and meta-analysis. Int J Technol Assess Health Care. 2019;35:298–306.

    PubMed  Google Scholar 

  19. Roberts CT, Owen LS, Manley BJ, Froisland DH, Donath SM, Dalziel KM, et al. Nasal high-flow therapy for primary respiratory support in preterm infants. N Engl J Med. 2016;375:1142–51.

    PubMed  Google Scholar 

  20. Klingenberg C, Wheeler KI, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in neonates. Cochrane Database Syst Rev. 2017;10:CD003666.

    PubMed  Google Scholar 

  21. Kramer BW, Kallapur S, Newnham J, Jobe AH. Prenatal inflammation and lung development. Semin Fetal Neonatal Med. 2009;14:2–7.

    PubMed  Google Scholar 

  22. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002;140:171–6.

    PubMed  Google Scholar 

  23. Kasper DC, Mechtler TP, Bohm J, Petricevic L, Gleiss A, Spergser J, et al. In utero exposure to Ureaplasma spp. is associated with increased rate of bronchopulmonary dysplasia and intraventricular hemorrhage in preterm infants. J Perinat Med. 2011;39:331–6.

    PubMed  Google Scholar 

  24. Olomu IN, Hecht JL, Onderdonk AO, Allred EN, Leviton A. Extremely low gestational age newborn study I. Perinatal correlates of Ureaplasma urealyticum in placenta parenchyma of singleton pregnancies that end before 28 weeks of gestation. Pediatrics. 2009;123:1329–36.

    PubMed  Google Scholar 

  25. Witt A, Berger A, Gruber CJ, Petricevic L, Apfalter P, Worda C, et al. Increased intrauterine frequency of Ureaplasma urealyticum in women with preterm labor and preterm premature rupture of the membranes and subsequent cesarean delivery. Am J Obstet Gynecol. 2005;193:1663–9.

    PubMed  Google Scholar 

  26. Viscardi RM, Terrin ML, Magder LS, Davis NL, Dulkerian SJ, Waites KB, et al. Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2020;105:615–22.

    PubMed  Google Scholar 

  27. Ding L, Wang H, Geng H, Cui N, Huang F, Zhu X, et al. Prediction of bronchopulmonary dysplasia in preterm infants using postnatal risk factors. Front Pediatr. 2020;8:349.

    PubMed  PubMed Central  Google Scholar 

  28. Saldeno YP, Favareto V, Mirpuri J. Prolonged persistent patent ductus arteriosus: potential perdurable anomalies in premature infants. J Perinatol. 2012;32:953–8.

    CAS  PubMed  Google Scholar 

  29. Mirza H, Garcia J, McKinley G, Hubbard L, Sensing W, Schneider J, et al. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants. J Perinatol. 2019;39:1648–55.

    CAS  PubMed  Google Scholar 

  30. Clyman RI, Liebowitz M, Kaempf J, Erdeve O, Bulbul A, Hakansson S, et al. PDA-TOLERATE trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age. J Pediatr. 2019;205:41–8 e6.

    PubMed  Google Scholar 

  31. Sung SI, Lee MH, Ahn SY, Chang YS, Park WS. Effect of nonintervention vs oral ibuprofen in patent ductus arteriosus in preterm infants: a randomized clinical trial. JAMA Pediatr. 2020;174:755–63.

    PubMed  Google Scholar 

  32. Clyman RI, Hills NK. The effect of prolonged tracheal intubation on the association between patent ductus arteriosus and bronchopulmonary dysplasia (grades 2 and 3). J Perinatol. 2020;40:1358–65.

    PubMed  PubMed Central  Google Scholar 

  33. Clyman RI, Kaempf J, Liebowitz M, Erdeve O, Bulbul A, Hakansson S, et al. Prolonged tracheal intubation and the association between patent ductus arteriosus and bronchopulmonary dysplasia: a secondary analysis of the PDA-TOLERATE trial. J Pediatr. 2021;229:283–8 e2.

    PubMed  Google Scholar 

  34. Wang L, Zhong WH, Liu DY, Shen HQ, He ZJ. Metabolic analysis of infants with bronchopulmonary dysplasia under early nutrition therapy: an observational cohort study. Exp Biol Med (Maywood). 2021. https://doi.org/10.1177/15353702211060513.

    Article  Google Scholar 

  35. Wemhoner A, Ortner D, Tschirch E, Strasak A, Rudiger M. Nutrition of preterm infants in relation to bronchopulmonary dysplasia. BMC Pulm Med. 2011;11:7.

    PubMed  PubMed Central  Google Scholar 

  36. Dassios T, Williams EE, Hickey A, Bunce C, Greenough A. Bronchopulmonary dysplasia and postnatal growth following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed. 2021;106:386–91.

    PubMed  Google Scholar 

  37. Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2014. https://doi.org/10.1002/14651858.CD000503.pub3.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, et al. Caffeine therapy for apnea of prematurity. N Engl J Med. 2006;354:2112–21.

    CAS  PubMed  Google Scholar 

  39. Amaro CM, Bello JA, Jain D, Ramnath A, D’Ugard C, Vanbuskirk S, et al. Early caffeine and weaning from mechanical ventilation in preterm infants: a randomized, placebo-controlled trial. J Pediatr. 2018;196:52–7.

    CAS  PubMed  Google Scholar 

  40. Dobson NR, Patel RM, Smith PB, Kuehn DR, Clark J, Vyas-Read S, et al. Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants. J Pediatr. 2014;164:992–8 e3.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Doyle LW, Cheong JL, Hay S, Manley BJ, Halliday HL. Late (≥ 7 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst Rev. 2021;11:CD001145.

    PubMed  Google Scholar 

  42. Zeng L, Tian J, Song F, Li W, Jiang L, Gui G, et al. Corticosteroids for the prevention of bronchopulmonary dysplasia in preterm infants: a network meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2018;103:F506–11.

    PubMed  Google Scholar 

  43. Shah SS, Ohlsson A, Halliday HL, Shah VS. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates. Cochrane Database Syst Rev. 2017;10:CD002058.

    PubMed  Google Scholar 

  44. Moreira A, Winter C, Joy J, Winter L, Jones M, Noronha M, et al. Intranasal delivery of human umbilical cord Wharton’s jelly mesenchymal stromal cells restores lung alveolarization and vascularization in experimental bronchopulmonary dysplasia. Stem Cells Transl Med. 2020;9:221–34.

    CAS  PubMed  Google Scholar 

Download references

Funding

This work was supported by grants from the National Natural Science Foundation of China (No.81873845).

Author information

Authors and Affiliations

  1. Division of NICU, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou, 310052, China

    Yan-Ping Xu, Li-Ping Shi & Li-Zhong Du

Authors
  1. Yan-Ping Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-Ping Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Li-Zhong Du
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

XYP contributed to writing of original draft. SLP and DLZ contributed to revision and editing for the paper.

Corresponding author

Correspondence to Yan-Ping Xu.

Ethics declarations

Ethical approval

Not required.

Conflict of interest

No financial or non-financial conflict of interests have been received.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, YP., Shi, LP. & Du, LZ. Continuing interventions in a quality improvement bundle to reduce bronchopulmonary dysplasia. World J Pediatr 18, 278–282 (2022). https://doi.org/10.1007/s12519-021-00508-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-021-00508-y

Search

Navigation